Nevertheless, plenty of clinical samples are needed to elucidate the exact molecular mechanisms/activity of the KCNQ1OT1/miR-329-3p/CTNND1 axis during the progression of CRC and to further explore other possible targets of KCNQ1OT1 in CRC. The gene discussed is KCNQ1OT1; the disease is colorectal carcinoma.